Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial. Issue 2 (1st February 2016) - Delforge, Michel; Devos, Timothy; Rowe, Jacob; Español, Ignacio; Durrant, Simon T.; Raddoux, Jolien; Boogaerts, Marc; Gramatzki, Martin; Gunther, Andreas